LuciRit 50mg Capsule (Ritlecitinib)

LuciRit 50mg Capsule contains Ritlecitinib, a prescription kinase inhibitor used for the treatment of severe alopecia areata in adults and adolescents aged 12 years and older. Alopecia areata is an autoimmune condition that causes hair loss, commonly affecting the scalp and sometimes other areas of the body.

LuciRit 50mg is manufactured by Lucius Pharmaceuticals and supplied in a pack of 28 capsules. Ritlecitinib works by inhibiting specific signaling pathways involved in immune activity, including Janus kinase 3 (JAK3) and the TEC family of kinases.

Product Information

• Product Name: LuciRit 50mg Capsule
• Active Ingredient: Ritlecitinib
• Strength: 50mg
• Dosage Form: Capsule
• Manufacturer: Lucius Pharmaceuticals
• Pack Size: 28 Capsules
• Therapeutic Category: Kinase inhibitor
• Primary Use: Severe alopecia areata

What Is LuciRit 50mg Capsule Used For?

LuciRit 50mg Capsule is used to treat severe alopecia areata in adults and adolescents aged 12 years and older.

Alopecia areata occurs when the immune system mistakenly attacks hair follicles, resulting in hair loss. Severe cases may involve extensive scalp hair loss, including alopecia totalis or alopecia universalis.

Ritlecitinib helps modify the abnormal immune signaling involved in alopecia areata and may support the regrowth of scalp hair in appropriate patients.

How Does Ritlecitinib Work?

Ritlecitinib is a kinase inhibitor. It irreversibly inhibits JAK3 and members of the TEC kinase family, interfering with signaling pathways involved in immune-cell activity. By modifying these pathways, ritlecitinib can reduce immune-mediated processes that contribute to hair follicle damage in alopecia areata.

Benefits of LuciRit 50mg Capsule

When prescribed appropriately, LuciRit 50mg may help:

• Treat severe alopecia areata.
• Reduce autoimmune activity involved in hair loss.
• Promote scalp hair regrowth in suitable patients.
• Improve the extent of scalp hair coverage.
• Provide a targeted oral treatment option for eligible patients.

Treatment response varies between individuals, and continued therapy should be evaluated by a healthcare professional.

LuciRit 50mg Dosage

The recommended dosage of ritlecitinib is 50mg once daily. It may be taken with or without food. Treatment should be initiated and supervised by a healthcare professional experienced in diagnosing and treating alopecia areata.

Your doctor may recommend laboratory testing before and during treatment. Do not change the dose or stop treatment without medical advice.

How to Take LuciRit 50mg Capsule

• Take one capsule once daily, or exactly as prescribed.
• It can generally be taken with or without food.
• Swallow the capsule whole with water.
• Do not crush, split, or chew the capsule.
• Try to take it at the same time each day.
• If you miss a dose, follow your healthcare professional’s instructions.
• Do not take extra capsules to compensate for a missed dose.

Possible Side Effects

Like other prescription medicines, ritlecitinib may cause side effects. Reported or clinically important adverse effects can include:

• Headache
• Diarrhea
• Acne
• Nausea
• Upper respiratory tract infections
• Folliculitis
• Dizziness
• Increased blood creatine phosphokinase levels
• Rash
• Hives

Your doctor should be informed about persistent, severe, or unusual symptoms.

Serious Side Effects

Ritlecitinib can increase the risk of serious infections, including bacterial, viral, fungal, and opportunistic infections. Tuberculosis is an important potential concern. Serious hypersensitivity reactions, blood-count abnormalities, malignancies, cardiovascular events, and thrombosis have also been identified as important risks associated with JAK-inhibitor therapy.

Seek immediate medical attention if you develop severe breathing difficulty, facial or throat swelling, persistent fever, serious infection symptoms, chest pain, sudden weakness, or symptoms suggestive of a blood clot.

Important Warnings and Precautions

Before starting LuciRit 50mg, inform your doctor if you have:

• An active or previous serious infection.
• Tuberculosis or exposure to tuberculosis.
• Hepatitis B or hepatitis C.
• A history of recurrent infections.
• Liver disease.
• Low white blood cell or platelet counts.
• A history of cancer.
• Cardiovascular disease or cardiovascular risk factors.
• A history of blood clots.
• Any condition requiring regular medicines.

Patients should be evaluated for tuberculosis and viral hepatitis before treatment. Blood counts, including lymphocyte and platelet levels, should also be assessed before treatment and monitored during therapy.

Risk of Infections

Because ritlecitinib affects immune signaling, it can increase susceptibility to infections. Treatment should generally not be started in patients with active tuberculosis, and appropriate screening for TB and viral hepatitis is recommended before treatment.

Contact your doctor if you develop fever, persistent cough, unexplained weight loss, painful urination, skin infections, or other signs of infection.

If a serious infection develops, your healthcare professional may temporarily interrupt treatment until the infection is controlled.

Blood Test Monitoring

Ritlecitinib can affect blood-cell counts. Healthcare professionals may monitor:

• Absolute lymphocyte count
• Platelet count
• Liver function
• Other laboratory parameters when clinically appropriate

Current prescribing information recommends checking lymphocyte and platelet counts before treatment and approximately 4 weeks after starting therapy, with further monitoring according to routine patient management.

Pregnancy and Breastfeeding

Tell your healthcare professional if you are pregnant, planning to become pregnant, or breastfeeding.

The effects of ritlecitinib during pregnancy and breastfeeding should be discussed with a qualified healthcare professional before treatment is started.

Drug Interactions

Ritlecitinib may interact with other medicines. Tell your doctor about all prescription medicines, over-the-counter medicines, vitamins, and herbal supplements you use.

LuciRit should not generally be combined with:

• Other JAK inhibitors
• Biologic immunomodulators
• Cyclosporine
• Other potent immunosuppressive medicines

Your doctor should review your complete medication list before starting treatment.

Contraindications

LuciRit 50mg should not be used by patients with a known hypersensitivity to ritlecitinib or any of its ingredients.

Treatment initiation may also be inappropriate in certain patients with active infections, significant blood-count abnormalities, or other medical conditions. Your healthcare professional should determine whether ritlecitinib is appropriate for you.

Storage Information

Store LuciRit 50mg Capsule according to the manufacturer’s instructions. Keep the medicine in its original packaging and protect it from excessive heat and moisture.

Keep out of reach of children and do not use the capsules after the expiry date.

Frequently Asked Questions

What is LuciRit 50mg Capsule?

LuciRit 50mg Capsule contains Ritlecitinib, a kinase inhibitor used for the treatment of severe alopecia areata in adults and adolescents aged 12 years and older.

What is ritlecitinib used for?

Ritlecitinib is used to treat severe alopecia areata, an autoimmune condition that causes hair loss.

What is the recommended dose of ritlecitinib?

The recommended dose is 50mg once daily for the approved indication.

Can LuciRit 50mg regrow hair?

Ritlecitinib can promote scalp hair regrowth in some patients with severe alopecia areata. The amount and speed of regrowth vary from person to person.

Can teenagers use ritlecitinib?

Ritlecitinib is indicated for severe alopecia areata in adolescents aged 12 years and older, as well as adults.

Does ritlecitinib require blood tests?

Yes. Blood counts, including lymphocyte and platelet counts, are recommended before treatment and during therapy. Other monitoring may also be required depending on the patient’s health.

Can I take LuciRit with other JAK inhibitors?

Ritlecitinib is not recommended for use together with other JAK inhibitors, biologic immunomodulators, cyclosporine, or other potent immunosuppressants. Always inform your doctor about your current medicines.

Why Choose LuciRit 50mg Capsule?

LuciRit 50mg Capsule (Ritlecitinib) provides an oral targeted treatment option for eligible patients with severe alopecia areata. It contains 50mg of ritlecitinib and is supplied by Lucius Pharmaceuticals in a convenient 28-capsule pack.

If LuciRit 50mg has been prescribed for you, follow your healthcare professional’s directions carefully and attend recommended laboratory and clinical follow-ups.

Medical Disclaimer: This information is provided for educational purposes only and does not replace professional medical advice, diagnosis, or treatment. LuciRit 50mg Capsule is a prescription medicine and should only be used under the supervision of a qualified healthcare professional.